ıv morphine PCA
PreclinicalSmall molecule
ıv morphine PCA is one of 63 small molecule programs targeting Anesthesia. It is currently in Preclinical.
2
Indications
3
Total Trials
2
Active Trials
62
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
64 competitors in Post Operative Pain
#DrugCompanyPhaseTrials
1Advil
KKenvue Brands
Approved
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Approved
Duragesic
CCephalon
Approved
Journavx
Vertex PharmaceuticalsApproved
Tylenol
KKenvue Brands
Approved
Ketalar
AAultman Health Foundation
Approved
Oxycontin
PProtega
Approved
Suboxone
IIndivior Inc.
Approved
Achromycin V
WWyeth-Lederle Vaccines
Approved
EXPAREL
Pacira Pharmaceuticals, IncApproved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for ıv morphine PCA. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- OOndokuz Mayıs University